Martha Pizzarello, MD
Obstetrics & Gynecology · Providence, RINPI 1154311314
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.8%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 65.1% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $2,348 and has fallen 79.5% since, to $482 in 2025.
Across 92 payments — averaging $49.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Exeltis, USA Inc.$365
- Astellas Pharma US Inc$351
- Galderma Laboratories, L.p.$124
- Bayer$109
- Coopersurgical, Inc.$81
- plus $560 from 17 others
What the payments were for
- Speaking & faculty fees$2,50055%
- Food & beverage$2,03145%
- Education$311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $2,970 |
| Exeltis, USA Inc. | 15 | $365 |
| Astellas Pharma US Inc | 14 | $351 |
| Galderma Laboratories, L.p. | 1 | $124 |
| Bayer | 6 | $109 |
| Coopersurgical, Inc. | 4 | $81 |
| Myovant Sciences Inc. | 4 | $80 |
| Pfizer | 4 | $77 |
| Hologic Sales And Service, LLC | 3 | $60 |
| Mylan Pharmaceuticals Inc. | 3 | $57 |
| Evofem Biosciences, Inc. | 2 | $34 |
| Merck | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Sage Therapeutics, LLC | 1 | $26 |
| Mayne Pharma Commercial LLC | 1 | $24 |
| AMAG Pharmaceuticals, Inc. | 1 | $22 |
| Agile Therapeutics, Inc. | 1 | $22 |
| BD | 1 | $19 |
| Boston Scientific | 1 | $19 |
| Organon | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Roche Diagnostics Corporation | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$114
How this compares
$4,562 in reported general payments places this provider in the 85th percentile of 139 obstetrics & gynecology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| YuvafemEstradiol | 12 | $2,313 |
| ValacyclovirValacyclovir Hcl | 17 | $625 |
| Estradiol | 13 | $536 |
| Clobetasol Propionate | 14 | $211 |
| Fluconazole | 11 | $67 |
| Misoprostol | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Providence
- Warren HuberProvidence$50K
- Lisa BoyleProvidence$30K
- Renee EgerProvidence$24K
- Gary WhartonProvidence$22K
- Christine FoleyProvidence$21K
- Cara MathewsProvidence$21K
- Michael BeitleProvidence$9K
- Ogechukwu EzikeProvidence$7K
- Beata DizoglioProvidence$6K
- Michele GangeProvidence$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.